Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Active Not Recruiting Phase 1 Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0088318 (Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01935921Ipilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreated Stage III-IVB Head and Neck CancerTreatment